Literature DB >> 10485556

Retinal vein occlusion associated with methylenetetrahydrofolate reductase mutation.

A Loewenstein1, M Goldstein, A Winder, M Lazar, A Eldor.   

Abstract

OBJECTIVE: To report on the occurrence of methylenetetrahydrofolate reductase (MTHFR) deficiency in patients with retinal vein occlusion (RVO).
DESIGN: Prospective case series PARTICIPANTS: Fifty-nine consecutive patients with newly diagnosed RVO seen at the Retina Unit in the Tel Aviv Medical Center during 1997. METHODS/TESTING: Interviews and multiple blood analyses were done. Data were compared to the reported incidence of MTHFR deficiency in the Israeli population at large.
RESULTS: Twenty-six patients (44.1%) were heterozygotes and 11 (18.6%) were homozygotes for 677C-T mutation in MTHFR. The MTHFR 677C-T homozygosity was documented as being present in 10.4% of healthy individuals in the Israeli population. The difference in homozygosity was found to be statistically significant (P = 0.038).
CONCLUSIONS: Retinal vein occlusion may be associated with a mutation in MTHFR.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10485556     DOI: 10.1016/S0161-6420(99)90357-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

Review 1.  Thrombophilia: genetic polymorphisms and their association with retinal vascular occlusive disease.

Authors:  M Chak; G R Wallace; E M Graham; M R Stanford
Journal:  Br J Ophthalmol       Date:  2001-07       Impact factor: 4.638

2.  Hyperhomocysteinemia: a new risk factor for central retinal vein occlusion.

Authors:  A K Vine
Journal:  Trans Am Ophthalmol Soc       Date:  2000

3.  Thermolabile MTHFR genotype and retinal vascular occlusive disease.

Authors:  M Cahill; M Karabatzaki; C Donoghue; R Meleady; L A Mynett-Johnson; D Mooney; I M Graham; A S Whitehead; D C Shields
Journal:  Br J Ophthalmol       Date:  2001-01       Impact factor: 4.638

4.  Levels of circulating homocysteine, vitamin B6, vitamin B12, and folate in different types of open-angle glaucoma.

Authors:  Burak Turgut; Murat Kaya; Sermal Arslan; Tamer Demir; Mete Güler; Mehmet Kaan Kaya
Journal:  Clin Interv Aging       Date:  2010-04-26       Impact factor: 4.458

5.  Cardiovascular risk factors and outcome in patients with retinal vein occlusion.

Authors:  Mirko Di Capua; Antonio Coppola; Rosina Albisinni; Antonella Tufano; Anna Guida; Matteo Nicola Dario Di Minno; Ferdinando Cirillo; Marcello Loffredo; Anna Maria Cerbone
Journal:  J Thromb Thrombolysis       Date:  2010-07       Impact factor: 2.300

6.  Serum homocysteine, vitamin B 12 and folic acid levels in different types of glaucoma.

Authors:  Tongabay Cumurcu; Semsettin Sahin; Erdinc Aydin
Journal:  BMC Ophthalmol       Date:  2006-02-23       Impact factor: 2.209

7.  Methylenetetrahydrofolate reductase C677T mutation and risk of retinal vein thrombosis.

Authors:  Mohammad Soleiman Soltanpour; Zahra Soheili; Ali Shakerizadeh; Ali Akbar Pourfathollah; Shahram Samiei; Reza Meshkani; Mohammad Shahjahani; Abbas Karimi
Journal:  J Res Med Sci       Date:  2013-06       Impact factor: 1.852

Review 8.  Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: an updated meta-analysis.

Authors:  Dan Li; Minwen Zhou; Xiaoyan Peng; Huiyu Sun
Journal:  BMC Ophthalmol       Date:  2014-11-27       Impact factor: 2.209

Review 9.  Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities.

Authors:  Jiri Rehak; Matus Rehak
Journal:  Curr Eye Res       Date:  2008-02       Impact factor: 2.424

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.